These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 16837072)

  • 1. Coronaviruses and their therapy.
    Haagmans BL; Osterhaus AD
    Antiviral Res; 2006 Sep; 71(2-3):397-403. PubMed ID: 16837072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug targets in severe acute respiratory syndrome (SARS) virus and other coronavirus infections.
    Tong TR
    Infect Disord Drug Targets; 2009 Apr; 9(2):223-45. PubMed ID: 19275708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Broad-spectrum coronavirus antiviral drug discovery.
    Totura AL; Bavari S
    Expert Opin Drug Discov; 2019 Apr; 14(4):397-412. PubMed ID: 30849247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alisporivir inhibits MERS- and SARS-coronavirus replication in cell culture, but not SARS-coronavirus infection in a mouse model.
    de Wilde AH; Falzarano D; Zevenhoven-Dobbe JC; Beugeling C; Fett C; Martellaro C; Posthuma CC; Feldmann H; Perlman S; Snijder EJ
    Virus Res; 2017 Jan; 228():7-13. PubMed ID: 27840112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapies for coronaviruses. Part 2: Inhibitors of intracellular life cycle.
    Tong TR
    Expert Opin Ther Pat; 2009 Apr; 19(4):415-31. PubMed ID: 19441924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapies for coronaviruses. Part I of II -- viral entry inhibitors.
    Tong TR
    Expert Opin Ther Pat; 2009 Mar; 19(3):357-67. PubMed ID: 19449500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remdesivir against COVID-19 and Other Viral Diseases.
    Malin JJ; Suárez I; Priesner V; Fätkenheuer G; Rybniker J
    Clin Microbiol Rev; 2020 Dec; 34(1):. PubMed ID: 33055231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal models for SARS and MERS coronaviruses.
    Gretebeck LM; Subbarao K
    Curr Opin Virol; 2015 Aug; 13():123-9. PubMed ID: 26184451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion.
    Coleman CM; Sisk JM; Mingo RM; Nelson EA; White JM; Frieman MB
    J Virol; 2016 Oct; 90(19):8924-33. PubMed ID: 27466418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease.
    Agostini ML; Andres EL; Sims AC; Graham RL; Sheahan TP; Lu X; Smith EC; Case JB; Feng JY; Jordan R; Ray AS; Cihlar T; Siegel D; Mackman RL; Clarke MO; Baric RS; Denison MR
    mBio; 2018 Mar; 9(2):. PubMed ID: 29511076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS, MERS and SARS-CoV-2 (COVID-19) treatment: a patent review.
    Nascimento Junior JAC; Santos AM; Quintans-Júnior LJ; Walker CIB; Borges LP; Serafini MR
    Expert Opin Ther Pat; 2020 Aug; 30(8):567-579. PubMed ID: 32429703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status of anti-SARS agents.
    Shigeta S; Yamase T
    Antivir Chem Chemother; 2005; 16(1):23-31. PubMed ID: 15739619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronaviruses: An Updated Overview of Their Replication and Pathogenesis.
    Wang Y; Grunewald M; Perlman S
    Methods Mol Biol; 2020; 2203():1-29. PubMed ID: 32833200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protease inhibitors targeting coronavirus and filovirus entry.
    Zhou Y; Vedantham P; Lu K; Agudelo J; Carrion R; Nunneley JW; Barnard D; Pöhlmann S; McKerrow JH; Renslo AR; Simmons G
    Antiviral Res; 2015 Apr; 116():76-84. PubMed ID: 25666761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity of SARS/MERS CoV to interferons and other drugs based on achievable serum concentrations in humans.
    Strayer DR; Dickey R; Carter WA
    Infect Disord Drug Targets; 2014; 14(1):37-43. PubMed ID: 25019238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of SARS-CoV replication by siRNA.
    Wu CJ; Huang HW; Liu CY; Hong CF; Chan YL
    Antiviral Res; 2005 Jan; 65(1):45-8. PubMed ID: 15652970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of cyclophilin A during coronavirus replication and the antiviral activities of its inhibitors].
    Tian L; Liu W; Sun L
    Sheng Wu Gong Cheng Xue Bao; 2020 Apr; 36(4):605-611. PubMed ID: 32347055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human coronaviruses and therapeutic drug discovery.
    Song LG; Xie QX; Lao HL; Lv ZY
    Infect Dis Poverty; 2021 Mar; 10(1):28. PubMed ID: 33726861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleoside analogues for the treatment of coronavirus infections.
    Pruijssers AJ; Denison MR
    Curr Opin Virol; 2019 Apr; 35():57-62. PubMed ID: 31125806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-beta 1a and SARS coronavirus replication.
    Hensley LE; Fritz LE; Jahrling PB; Karp CL; Huggins JW; Geisbert TW
    Emerg Infect Dis; 2004 Feb; 10(2):317-9. PubMed ID: 15030704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.